Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis
Authors
Keywords
Anticoagulants, Low molecular weight heparin, Venous thromboembolism, Evidence-based practice, Meta-analysis
Journal
Internal and Emergency Medicine
Volume 12, Issue 8, Pages 1291-1305
Publisher
Springer Nature
Online
2017-07-29
DOI
10.1007/s11739-017-1714-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis
- (2017) Brett T. Venker et al. JOURNAL OF ARTHROPLASTY
- Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials
- (2016) Aaron Y. L. Liew et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
- (2016) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials
- (2016) Guang-Zhi Ning et al. Scientific Reports
- Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation
- (2015) Maria C. S. Inacio et al. BMC MUSCULOSKELETAL DISORDERS
- Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies
- (2015) Giancarlo Agnelli et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose–response meta-analysis and network meta-analysis
- (2015) Weili Feng et al. THROMBOSIS RESEARCH
- Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials
- (2015) Guofeng Ma et al. THROMBOSIS RESEARCH
- A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal
- (2014) Noel C. Chan et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Comparative Effectiveness of New Oral Anticoagulants and Standard Thromboprophylaxis in Patients Having Total Hip or Knee Replacement
- (2013) Soheir S. Adam et al. ANNALS OF INTERNAL MEDICINE
- Relative Effects of Two Different Enoxaparin Regimens as Comparators Against Newer Oral Anticoagulants
- (2013) Chun Shing Kwok et al. CHEST
- Apixaban and Rivaroxaban Decrease Deep Venous Thrombosis But Not Other Complications After Total Hip and Total Knee Arthroplasty
- (2013) Robert D. Russell et al. JOURNAL OF ARTHROPLASTY
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
- (2013) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment
- (2013) A. G. G. Turpie et al. THROMBOSIS AND HAEMOSTASIS
- Prevention of VTE in Orthopedic Surgery Patients
- (2012) Yngve Falck-Ytter et al. CHEST
- Introduction to the Ninth Edition
- (2012) Gordon H. Guyatt et al. CHEST
- Executive Summary
- (2012) Gordon H. Guyatt et al. CHEST
- Prevention of VTE in Nonsurgical Patients
- (2012) Susan R. Kahn et al. CHEST
- Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients
- (2012) Ida Ehlers Albertsen et al. DRUGS
- Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery
- (2012) J. Harenberg et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
- (2012) A. Gomez-Outes et al. BMJ-British Medical Journal
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- (2011) Samuel Z. Goldhaber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients
- (2011) Ajay K. Kakkar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
- (2011) Ola Dahl et al. THROMBOSIS AND HAEMOSTASIS
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
- (2010) S. BARBAR et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
- (2010) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Editorial Board
- (2009) JOURNAL OF ARTHROPLASTY
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started